The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Pyxis Oncology Inc’s current trading price is -72.26% away from its 52-week high, while its distance from the 52-week low is 40.74%. The stock’s price range for this period has been between $1.35 and $6.85 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 4.14 million for the day, a number notably higher than the average daily volume of 0.84 million over the last three months.
Pyxis Oncology Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $6.85 on 02/27/24 and a low of $1.35 for the same time frame on 11/24/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Pyxis Oncology Inc (PYXS) has experienced a quarterly decline of -50.13% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 102.22M and boasts a workforce of 50 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.5710, with a change in price of -0.9800. Similarly, Pyxis Oncology Inc recorded 766,278 in trading volume during the last 100 days, posting a change of -34.03%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for PYXS stands at 0.13. Similarly, the long-term debt-to-equity ratio is also 0.12.
PYXS Stock Stochastic Average
As of today, Pyxis Oncology Inc’s raw stochastic average for the last 50 days stands at 0.29%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 0.29%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 6.74% and 18.49%, respectively.
PYXS Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded an increase of 5.56%. However, over the last six months, the performance has been stronger by -50.13%. The price of PYXS decreased -49.33% over the last 30 days. And in the last five days, it has fallen by -54.65%.
